| ADNRX | RPMGX | ADNRX / RPMGX | |
| Total Expense Ratio | 1.05 | 0.75 | 140% |
| Annual Report Gross Expense Ratio | 1.18 | 0.75 | 157% |
| Fund Existence | 5 years | 34 years | - |
| Gain YTD | -4.479 | -0.134 | 3,350% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 169M | 25.1B | 1% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 19.39 | -5.89 | -329% |
| Returns for 3 years | 73.61 | -0.15 | -50,758% |
| Returns for 5 years | -61.82 | -16.66 | 371% |
| Returns for 10 years | N/A | 50.88 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| TASMX | 29.23 | -0.10 | -0.34% |
| Transamerica Small/Mid Cap Value R6 | |||
| NUGIX | 34.71 | -0.15 | -0.43% |
| Nuveen Global Dividend Growth I | |||
| AEYGX | 35.97 | -0.42 | -1.15% |
| American Century Equity Growth R5 | |||
| PLGAX | 13.45 | -0.35 | -2.54% |
| Principal LargeCap Growth I A | |||
| DAFGX | 31.46 | -0.90 | -2.78% |
| Dunham Focused Large Cap Growth A | |||